Dogwood Therapeutics Inc. (DWTX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
7.50
-1.27 (-14.48%)
At close: Feb 11, 2025, 3:59 PM
7.65
2.00%
After-hours Feb 11, 2025, 06:00 PM EST
undefined% (undefined)
Bid | 7.35 |
Market Cap | 9.99M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -5.16 |
PE Ratio (ttm) | -1.45 |
Forward PE | n/a |
Analyst | n/a |
Ask | 7.65 |
Volume | 501,953 |
Avg. Volume (20D) | 2,654,031 |
Open | 9.09 |
Previous Close | 8.77 |
Day's Range | 6.81 - 9.70 |
52-Week Range | 1.62 - 29.28 |
Beta | undefined |
About DWTX
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, att...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 4
Stock Exchange NASDAQ
Ticker Symbol DWTX
Website https://www.dwtx.com
Why Price Moved
3 weeks ago
+68.45%
Dogwood Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
-37.71%
Dogwood Therapeutics shares are trading lower. The company announced top line data from the recently completed BHC IMC-2 Long-COVID study.